BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3032010)

  • 21. Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo).
    Andrews GA; Myers NC; Chard-Bergstrom C
    Vet Pathol; 1997 Sep; 34(5):387-93. PubMed ID: 9381649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours.
    Bordi C; Pilato FP; D'Adda T
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):387-98. PubMed ID: 2845642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endocrine differentiation in basocellular carcinoma].
    Collina G; Macrì L; Eusebi V
    Pathologica; 2001 Jun; 93(3):208-12. PubMed ID: 11433614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neural and endocrine markers as diagnostic tools in pancreatic and gastrointestinal endocrine tumors.
    Klöppel G; In't Veld P
    Acta Histochem Suppl; 1990; 38():93-8. PubMed ID: 1706875
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines.
    Poola I; Graziano SL
    J Exp Clin Cancer Res; 1998 Jun; 17(2):165-73. PubMed ID: 9700577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers.
    Hamid QA; Bishop AE; Sikri KL; Varndell IM; Bloom SR; Polak JM
    Histopathology; 1986 Feb; 10(2):119-33. PubMed ID: 3007321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transthyretin in endocrine pancreatic tumors.
    Jacobsson B; Carlström A; Collins VP; Grimelius L
    Am J Pathol; 1989 Feb; 134(2):465-71. PubMed ID: 2464944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of neuroendocrine feature about salivary adenoid cystic carcinoma.
    Sun C; Zhong M; Wang Z; Wang Y
    Chin J Dent Res; 1999 Dec; 2(3-4):65-7. PubMed ID: 10863420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
    Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
    Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine differentiation in colorectal carcinomas.
    Syversen U; Halvorsen T; Mårvik R; Waldum HL
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuron-specific enolase as a new tumor marker].
    Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1744-53. PubMed ID: 6349546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroendocrine lung structures and tumours: immunohistochemical study by specific markers.
    Mosca L; Barbareschi M; Mauri MF; Munguia-Barrera J; Frigo B; Muscarà M; Valentini L; Mariscotti C
    Histol Histopathol; 1988 Oct; 3(4):367-76. PubMed ID: 2980246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of so-called neuroendocrine lung tumors.
    Yesner R
    Exp Mol Pathol; 2001 Jun; 70(3):179-82. PubMed ID: 11417996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monoclonal antibodies to neuron-specific enolase in phenotyping lung cancer].
    Frank GA; Kazesalu IaS; Piĭrsoo AO; Litvinova LV; Vial'tsev NV
    Arkh Patol; 1992; 54(3):12-5. PubMed ID: 1444841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of neuroendocrine markers (neuronspecific enolase, synaptophysin and bombesin) in carcinoma of the lung.
    Kayser K; Schmid W; Ebert W; Wiedenmann B
    Pathol Res Pract; 1988 Aug; 183(4):412-7. PubMed ID: 3141909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
    Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
    Lung Cancer; 1994 Dec; 11(5-6):353-64. PubMed ID: 7535640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecules of regulated secretion are differentiation markers of neuroendocrine tumors].
    Schmitt-Gräff A; Müller H; Rancso C; Ahnert-Hilger G; John M; Riecken EO; Stein H; Wiedenmann B
    Verh Dtsch Ges Pathol; 1997; 81():157-61. PubMed ID: 9474867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.
    Asa SL; Ryan N; Kovacs K; Singer W; Marangos PJ
    Arch Pathol Lab Med; 1984 Jan; 108(1):40-3. PubMed ID: 6362613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.